Michael F Mahoney sold $16M of BSX
Chairman, President & CEO at BOSTON SCIENTIFIC CORP. 164,442 shares at an average of $100.01, traded Apr 1, 2025, filed Apr 2, 2025.
Score components
- +25RoleCEO
- +25Trade size$16.4M at market
- 0Share of holdings soldSold 9.3% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001225208-25-003866, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | MOption exercise Common Stock10b5-1 | +56,211 | $17.26 | $970k | 1,709,565 | Apr 2, 2025 |
| Apr 1, 2025 | MOption exercise Common Stock10b5-1 | +49,407 | $24.55 | $1.2M | 1,758,972 | Apr 2, 2025 |
| Apr 1, 2025 | SOpen-market sale Common Stock10b5-1 | -164,442 | $100.01 | $16M | 1,594,530 | Apr 2, 2025 |
| Apr 1, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -56,211 | $0.00 | $0 | 112,424 | Apr 2, 2025 |
| Apr 1, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -49,407 | $0.00 | $0 | 247,035 | Apr 2, 2025 |
Related signals
Other insiders at BOSTON SCIENTIFIC CORP and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | BOSTON SCIENTIFIC CORP | Joseph Michael Fitzgerald EVP & Group Pres, Cardiology | $5.8M 56,372 shares | -24% | |
| 35Weak | BOSTON SCIENTIFIC CORP | Michael F Mahoney Chairman, President & CEO | $17M 164,443 shares | -10% | |
| 51Moderate | BOSTON SCIENTIFIC CORP | Edward J Ludwig director | $418k 4,000 shares | -15% | |
| 33Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $514k 4,826 shares | -13% | |
| 18Weak | BOSTON SCIENTIFIC CORP | John Bradley Sorenson EVP, Global Operations | $478k 4,572 shares | -20% | |
| 40Moderate | BOSTON SCIENTIFIC CORP | Arthur C Butcher EVP& Grp Pres, MedSurg & APAC | $1.8M 17,314 shares | -44% | |
| 30Weak | BOSTON SCIENTIFIC CORP | Michael F Mahoney Chairman, President & CEO | $17M 164,443 shares | -10% | |
| 32Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $459k 4,826 shares | -12% | |
| 26Weak | BOSTON SCIENTIFIC CORP | Vance R Brown SVP, GC and Corp. Secretary | $487k 4,826 shares | -11% | |
| 37Weak | BOSTON SCIENTIFIC CORP | Emily Woodworth SVP, Global Controller and CAO | $801k 7,631 shares | -95% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.